Early stage and long term treatment of multiple sclerosis with interferon-β
Angela Applebee, Hillel PanitchDepartment of Neurology, University of Vermont College of Medicine, and Neurology Service, Fletcher Allen Health Care, Burlington, VT, USAAbstract: Multiple sclerosis (MS) affects young adults during the most productive years of their lives, and until recently many neu...
Guardado en:
Autores principales: | Angela Applebee, Hillel Panitch |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/092d155f8e394cb09f79438b176a78f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta
por: Castrop F, et al.
Publicado: (2013) -
Review of the clinical evidence for interferon β 1a (Rebif®) in the treatment of multiple sclerosis
por: Francesco Manfredonia, et al.
Publicado: (2008) -
Review of interferon beta-1b in the treatment of early and relapsing multiple sclerosis
por: Damiano Paolicelli, et al.
Publicado: (2009) -
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosis
por: Slobodan M Jankovic
Publicado: (2010) -
PEGylated interferon beta-1a in the treatment of multiple sclerosis – an update
por: Reuss R
Publicado: (2013)